Source: Virtual Congress 2020 – COPD phenotypes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Barrecheguren Fernandez (Barcelona, Spain), M. Sucena (Porto, Portugal), K. O´hara (UK, United Kingdom), M. Wilkens (Germany, Germany), J. Boyd (Sheffield, United Kingdom), E. Kolda (Poznan, Poland), A. Turner (Birmingham, United Kingdom), G. Mcelvaney (Dublin, Ireland), I. Ferrarotti (Pavia, Italy), J. Stolk (Leiden, Netherlands), J. Chorostowska-Wynimko (Warsaw, Poland), R. Stockley (Birmingham, United Kingdom), T. Greulich (Marburg, Germany), M. Miravitlles (Barcelona, Spain). Research priorities in alpha-1 antitrypsin deficiency (AATD) for healthcare professionals. 2430

Member's Comments

No comment yet.

Related content which might interest you: Expanding the awareness of Alpha-1 antitrypsin deficiency (AATD) to provide a multidisciplinary approach to care Source: Virtual Congress 2020 – Airway diseases Year: 2020 The Irish national alpha-1 antitrypsin deficiency targeted detection programme Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Implementation of screening program for alpha-1 antitrypsin deficiency in Spain Source: Annual Congress 2004 - Emphysema and oxygen therapy Year: 2004 Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Prevalence of alpha-1 antitrypsin deficiency (AATD) in Greater Glasgow and Clyde (GG&C) and current practises Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs Source: Breathe, 17 (1) 200340; 10.1183/20734735.0340-2020 Year: 2021 The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency Source: Eur Respir J, 53 (2) 1900138; 10.1183/13993003.00138-2019 Year: 2019 Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Diagnosis of alpha 1 antitrypsin deficiency in primary care Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Czech national alpha-1 antitrypsin registry Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Research priorities in a1-antitrypsin deficiency: results of a patients' and healthcare providers' international survey from the EARCO Clinical Research Collaboration Source: ERJ Open Res, 6 (4) 00523-2020; 10.1183/23120541.00523-2020 Year: 2020 Knowledge of alpha-1 deficiency and primary ciliary dyskinesia by medical students and health professionals Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood Year: 2016 Decline in health status in alpha1 antitrypsin deficiency Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil Source: Eur Respir J 2003; 22: Suppl. 45, 499s Year: 2003 The national alpha-1 antitrypsin deficiency registry in Poland Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 External quality assessment (EQA) for laboratory diagnosis of alpha1-antitrypsin deficiency (AATD) – Program driven by the European Alpha-1-Research Collaboration (EARCO) network Source: Virtual Congress 2021 – Pathogenic progress in airway diseases Year: 2021 Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014